The trademark application FOROBEX was filed by TEVA Pharmaceuticals Europe B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on October 4, 2021, and it was registered by office on January 11, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).